J
Jérôme Dulon
Researcher at University of Paris
Publications - 27
Citations - 790
Jérôme Dulon is an academic researcher from University of Paris. The author has contributed to research in topics: Congenital adrenal hyperplasia & Medicine. The author has an hindex of 13, co-authored 21 publications receiving 626 citations. Previous affiliations of Jérôme Dulon include Pierre-and-Marie-Curie University & Institute of Chartered Accountants of Nigeria.
Papers
More filters
Journal ArticleDOI
Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure.
Maud Bidet,Anne Bachelot,Estelle Bissauge,Jean Louis Golmard,Solenne Gricourt,Jérôme Dulon,Christiane Coussieu,Yasmina Badachi,Philippe Touraine +8 more
TL;DR: Intermittent ovarian activity in patients with POF is not a rare phenomenon, and the predictive score described in this study may help to identify POF patients most likely to recover intermittent ovarian function.
Journal ArticleDOI
Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure
Anne Bachelot,A. Rouxel,Nathalie Massin,Jérôme Dulon,Carine Courtillot,Christine Matuchansky,Yasmina Badachi,Anne Fortin,Bernard Paniel,Fabrice Lecuru,Marie-Aude Lefrère-Belda,Elisabeth Constancis,Elisabeth Thibault,Geri Meduri,Anne Guiochon-Mantel,Micheline Misrahi,Frédérique Kuttenn,Philippe Touraine +17 more
TL;DR: A genetic cause of POF was identified in 25 patients, i.e. 7% of the whole cohort, and novel strategies of P OF phenotyping are in such content mandatory to improve the rate of PTO patients for whom etiology is identified.
Journal ArticleDOI
MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency.
Swapna S. Desai,Michelle A. Wood-Trageser,Jelena Matic,Jaqueline Chipkin,Huaiyang Jiang,Anne Bachelot,Jérôme Dulon,Cinzia Sala,Caterina Barbieri,Massimiliano Cocca,Daniela Toniolo,Philippe Touraine,Selma F. Witchel,Aleksandar Rajkovic +13 more
TL;DR: A significant number of potentially damaging and novel variants in MCM8 and MCM9 among participants with POI are identified and multiallelic association with variants in DDR andMCM8-MCM9 interactome genes is examined.
Journal ArticleDOI
Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency.
Zeina Chakhtoura,Anne Bachelot,Dinane Samara-Boustani,Jean-Charles Ruiz,Bruno Donadille,Jérôme Dulon,Sophie Christin-Maitre,Claire Bouvattier,Marie-Charles Raux-Demay,Philippe Bouchard,Jean-Claude Carel,Juliane Léger,Frédérique Kuttenn,Michel Polak,Philippe Touraine +14 more
TL;DR: The TCG is an important factor especially during puberty for a bone demineralization in patients with 21-hydroxylase deficiency and the glucocorticoid treatment should be adapted particularly at this life period and preventive measures should be discussed in order to limit this effect.
Journal ArticleDOI
MANAGEMENT OF ENDOCRINE DISEASE: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: update on the management of adult patients and prenatal treatment.
TL;DR: The present overview focuses on studies dealing with cardiovascular risk, fertility, treatment and prenatal management in adults with classic CAH to provide the reader with an updated review on this rapidly evolving field of knowledge.